The China Mail - US researchers seek to legitimize AI mental health care

USD -
AED 3.673102
AFN 62.493319
ALL 81.650049
AMD 368.780249
ANG 1.79046
AOA 917.999616
ARS 1391.440285
AUD 1.38485
AWG 1.8025
AZN 1.697591
BAM 1.670681
BBD 2.014496
BDT 122.776371
BGN 1.66992
BHD 0.377299
BIF 2975
BMD 1
BND 1.273528
BOB 6.911397
BRL 5.004602
BSD 1.000201
BTN 95.835344
BWP 14.087599
BYN 2.794335
BYR 19600
BZD 2.011549
CAD 1.37225
CDF 2244.99985
CHF 0.783702
CLF 0.022735
CLP 894.791543
CNY 6.785151
CNH 6.78612
COP 3789.73
CRC 454.512452
CUC 1
CUP 26.5
CVE 94.702891
CZK 20.8311
DJF 177.719843
DKK 6.404399
DOP 59.700677
DZD 132.447999
EGP 52.867303
ERN 15
ETB 157.449907
EUR 0.85697
FJD 2.191597
FKP 0.739691
GBP 0.746365
GEL 2.680049
GGP 0.739691
GHS 11.409837
GIP 0.739691
GMD 72.499865
GNF 8779.999965
GTQ 7.630738
GYD 209.246802
HKD 7.83251
HNL 26.620617
HRK 6.458898
HTG 130.972363
HUF 306.545501
IDR 17535.3
ILS 2.902601
IMP 0.739691
INR 95.7091
IQD 1310
IRR 1315000.000078
ISK 123.180086
JEP 0.739691
JMD 158.141561
JOD 0.708994
JPY 158.39103
KES 129.250112
KGS 87.450082
KHR 4011.999726
KMF 421.999959
KPW 899.97066
KRW 1493.490202
KWD 0.30849
KYD 0.833543
KZT 473.448852
LAK 21955.000133
LBP 90063.841638
LKR 325.320759
LRD 183.250142
LSL 16.4899
LTL 2.95274
LVL 0.60489
LYD 6.330395
MAD 9.20875
MDL 17.192645
MGA 4177.499513
MKD 52.834798
MMK 2099.865061
MNT 3580.130218
MOP 8.069362
MRU 39.98999
MUR 46.895264
MVR 15.401208
MWK 1741.000482
MXN 17.225302
MYR 3.931505
MZN 63.910286
NAD 16.489493
NGN 1369.370618
NIO 36.714995
NOK 9.233501
NPR 153.332792
NZD 1.691475
OMR 0.384492
PAB 1.000184
PEN 3.44698
PGK 4.193011
PHP 61.460973
PKR 278.591881
PLN 3.636395
PYG 6094.852476
QAR 3.645502
RON 4.456702
RSD 100.601025
RUB 73.24798
RWF 1461
SAR 3.707824
SBD 8.016136
SCR 13.867581
SDG 600.503741
SEK 9.369043
SGD 1.2756
SHP 0.746601
SLE 24.650261
SLL 20969.502105
SOS 571.497017
SRD 37.206963
STD 20697.981008
STN 21.25
SVC 8.751249
SYP 110.528733
SZL 16.490133
THB 32.420153
TJS 9.346574
TMT 3.5
TND 2.888037
TOP 2.40776
TRY 45.464801
TTD 6.790867
TWD 31.544499
TZS 2595.000031
UAH 43.968225
UGX 3740.52909
UYU 39.831211
UZS 12044.999697
VES 510.148815
VND 26345
VUV 118.077659
WST 2.708521
XAF 560.318959
XAG 0.011986
XAU 0.000215
XCD 2.70255
XCG 1.802565
XDR 0.694969
XOF 557.509472
XPF 102.624995
YER 238.649788
ZAR 16.455495
ZMK 9001.134371
ZMW 18.82781
ZWL 321.999592
  • RBGPF

    -0.2100

    60.79

    -0.35%

  • CMSD

    0.0400

    23.6

    +0.17%

  • CMSC

    0.0898

    23.14

    +0.39%

  • NGG

    0.4500

    87.43

    +0.51%

  • JRI

    0.0100

    13.14

    +0.08%

  • BCC

    2.4200

    69.4

    +3.49%

  • BCE

    -0.2000

    24.19

    -0.83%

  • RIO

    -2.4500

    109.59

    -2.24%

  • GSK

    -0.0300

    50.96

    -0.06%

  • RELX

    -0.1600

    31.46

    -0.51%

  • BTI

    1.3500

    66.7

    +2.02%

  • RYCEF

    -0.0700

    15.93

    -0.44%

  • BP

    -0.0200

    44.12

    -0.05%

  • VOD

    -0.0300

    15.48

    -0.19%

  • AZN

    -2.7600

    184.96

    -1.49%

US researchers seek to legitimize AI mental health care
US researchers seek to legitimize AI mental health care / Photo: © GETTY IMAGES NORTH AMERICA/AFP/File

US researchers seek to legitimize AI mental health care

Researchers at Dartmouth College believe artificial intelligence can deliver reliable psychotherapy, distinguishing their work from the unproven and sometimes dubious mental health apps flooding today's market.

Text size:

Their application, Therabot, addresses the critical shortage of mental health professionals.

According to Nick Jacobson, an assistant professor of data science and psychiatry at Dartmouth, even multiplying the current number of therapists tenfold would leave too few to meet demand.

"We need something different to meet this large need," Jacobson told AFP.

The Dartmouth team recently published a clinical study demonstrating Therabot's effectiveness in helping people with anxiety, depression and eating disorders.

A new trial is planned to compare Therabot's results with conventional therapies.

The medical establishment appears receptive to such innovation.

Vaile Wright, senior director of health care innovation at the American Psychological Association (APA), described "a future where you will have an AI-generated chatbot rooted in science that is co-created by experts and developed for the purpose of addressing mental health."

Wright noted these applications "have a lot of promise, particularly if they are done responsibly and ethically," though she expressed concerns about potential harm to younger users.

Jacobson's team has so far dedicated close to six years to developing Therabot, with safety and effectiveness as primary goals.

Michael Heinz, psychiatrist and project co-leader, believes rushing for profit would compromise safety.

The Dartmouth team is prioritizing understanding how their digital therapist works and establishing trust.

They are also contemplating the creation of a nonprofit entity linked to Therabot to make digital therapy accessible to those who cannot afford conventional in-person help.

- Care or cash? -

With the cautious approach of its developers, Therabot could potentially be a standout in a marketplace of untested apps that claim to address loneliness, sadness and other issues.

According to Wright, many apps appear designed more to capture attention and generate revenue than improve mental health.

Such models keep people engaged by telling them what they want to hear, but young users often lack the savvy to realize they are being manipulated.

Darlene King, chair of the American Psychiatric Association's committee on mental health technology, acknowledged AI's potential for addressing mental health challenges but emphasizes the need for more information before determining true benefits and risks.

"There are still a lot of questions," King noted.

To minimize unexpected outcomes, the Therabot team went beyond mining therapy transcripts and training videos to fuel its AI app by manually creating simulated patient-caregiver conversations.

While the US Food and Drug Administration theoretically is responsible for regulating online mental health treatment, it does not certify medical devices or AI apps.

Instead, "the FDA may authorize their marketing after reviewing the appropriate pre-market submission," according to an agency spokesperson.

The FDA acknowledged that "digital mental health therapies have the potential to improve patient access to behavioral therapies."

- Therapist always in -

Herbert Bay, CEO of Earkick, defends his startup's AI therapist Panda as "super safe."

Bay says Earkick is conducting a clinical study of its digital therapist, which detects emotional crisis signs or suicidal ideation and sends help alerts.

"What happened with Character.AI couldn't happen with us," said Bay, referring to a Florida case in which a mother claims a chatbot relationship contributed to her 14-year-old son's death by suicide.

AI, for now, is suited more for day-to-day mental health support than life-shaking breakdowns, according to Bay.

"Calling your therapist at two in the morning is just not possible," but a therapy chatbot remains always available, Bay noted.

One user named Darren, who declined to provide his last name, found ChatGPT helpful in managing his traumatic stress disorder, despite the OpenAI assistant not being designed specifically for mental health.

"I feel like it's working for me," he said.

"I would recommend it to people who suffer from anxiety and are in distress."

K.Lam--ThChM